HeyJaredThe BioMedWire Podcast
CryptoCurrencyWire is a regular guest on the Wild West Crypto Show and other shows to share press releases of interest within the blockchain space.
- Indexed episodes, last 90 days
- 6
- Latest publication
- Sep 18, 2026
- Audience
- Checking…
- Earliest in this view
- Sep 10, 2026
Latest episodes
The BioMedWire Podcast Featuring Dr. Ehud Geller CEO of Regentis Biomaterials (NYSE American: RGNT) (opens the original)
Read excerpt
AUSTIN, Texas, September 18, 2026 – via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The BioMedWire Podcast delivers dynamic interviews with industry experts at the forefront of pharmaceutical and biotech advancement. The lates
The BioMedWire Podcast Featuring Dr. Ehud Geller, CEO of Regentis Biomaterials (NYSE American: RGNT) [Video Edition] (opens the original)
Read excerpt
AUSTIN, Texas, September 18, 2026 – via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The BioMedWire Podcast delivers dynamic interviews with industry experts at the forefront of pharmaceutical and biotech advancement. The lates
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach (opens the original)
Read excerpt
BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) drugs on the market today can slow the disease down, but none of them stop it, and none of them give patients back what they have already lost. Nearly one million people in the United States, and close to 2.9 million worldwide, live with that reality, watching a disease that can gradually erode mobility, vision, and basic bodily control. That gap has just gotten a serious new challenger. Quantum BioPharma Ltd. (NASDAQ: QNTM) (Profile) has
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach [Video Edition] (opens the original)
Read excerpt
BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) drugs on the market today can slow the disease down, but none of them stop it, and none of them give patients back what they have already lost. Nearly one million people in the United States, and close to 2.9 million worldwide, live with that reality, watching a disease that can gradually erode mobility, vision, and basic bodily control. That gap has just gotten a serious new challenger. Quantum BioPharma Ltd. (NASDAQ: QNTM) (Profile) has
The BioMedWire Podcast Featuring Dr. Islam Mohamed, Chief Medical Officer of Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) (opens the original)
Read excerpt
Disseminated on behalf of Onco-Innovations Ltd., may include paid advertisements. AUSTIN, Texas, September 10, 2026 – via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The BioMedWire Podcast delivers dynamic interviews with indu
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.